Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Hitachi, Ltd.    6501   JP3788600009

News SummaryMost relevantAll newsSector newsTweets 

Hitachi, Ltd. : MOU to Start Exclusive Negotiations on Supply of Proton Beam Therapy System to Hospital No. 63 in Moscow, Russia

share with twitter share with LinkedIn share with facebook
share via e-mail
12/26/2013 | 04:02am CET

Information contained in this news release is current as of the date of the press announcement, but may be subject to change without prior notice.

MOU to Start Exclusive Negotiations on Supply of Proton Beam
Therapy System to Hospital No. 63 in Moscow, Russia

Tokyo, December 26, 2013 --- Hitachi, Ltd. (TSE:6501) today announced that it has signed a memorandum of understanding (MOU) with Group of Companies European Medical Center (GEMC) in the Russian Federation,on the supply of a proton beam therapy system to hospital No. 63 in Moscow. Based on the MOU, Hitachi and GEMC will enter into exclusive negotiations with the aim of reaching a formal contract by the end of March 2014.

The irradiation of tumors with beams of accelerated particles (protons or carbon ions) has become recognized as a new form of cancer treatment. With a high incidence of cancer comparable to Japan or Europe, Russia is planning the construction of a number of new particle beam therapy facilities to strengthen its capabilities for treatment of the disease.

Backed by more than 20 years of history and tradition in Moscow, GEMC is one of the largest private medical service companies in Russia, operating 24-hour emergency clinics, pediatric hospitals, and women's hospitals at 5 locations in Moscow. The company is growing by creating private medical facilities, and providing them modern medical management and services in Moscow.

In April 2013, Hitachi entered into a strategic partnership with GEMC and the Budker Institute of Nuclear Physics (BINP) aimed at promoting the construction of hadron therapy systems in Russia. The new MOU announced today represents the first project to be initiated under this partnership. In addition to collaborating on construction through the supply of technical documents and other resources required for the building design, Hitachi will also be entering into exclusive negotiations toward a formal contract for supply of the system. It is expected that the contract will be signed by the end of March 2014.

Hitachi started developing proton beam therapy systems approximately 20 years ago. The technology has earned widespread recognition as an effective cancer treatment, with systems having been supplied to the University of Tsukuba and Nagoya Proton Therapy Center in Japan. Outside Japan, Hitachi has supplied a system to the MD Anderson Cancer Center in the USA, one of the world's largest specialist cancer hospitals. Particle beam therapy systems for Hokkaido University and three well-known clinics in the USA are currently under construction.

In addition to making an ongoing contribution to the wider adoption of advanced radiation therapy and other cancer treatments through the supply of particle beam therapy systems that incorporate leading-edge technologies such as spot scanning, Hitachi is also committed to the global operation of its healthcare and other social innovation businesses.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 326,000 employees worldwide. The company's consolidated revenues for fiscal 2012 (ended March 31, 2013) totaled 9,041 billion yen ($96.1 billion). Hitachi is focusing more than ever on the Social Innovation Business, which includes infrastructure systems, information & telecommunication systems, power systems, construction machinery, high functional material & components, automotive systems and others.http://www.hitachi.com.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on HITACHI, LTD.
08:43a Ten most active stocks on Tokyo Stock Exchange
02/24 HITACHI : Patent Issued for Organic Luminescent Materials, Coating Solution Usin..
02/24 HITACHI : Patent Issued for Medical Image Processing Apparatus and Medical Image..
02/24 HITACHI : Patent Issued for Ultrasonic Image Processing Apparatus (USPTO 9569818..
02/24 HITACHI METALS : Patent Issued for Optical Module (USPTO 9568694)
02/24 HITACHI CONSTRUCTION MACHINERY : Patent Issued for Work Machine (USPTO 9567730)
02/24 HITACHI HIGH TECHNOLOGIES : Promega Corporation Brings High-Performance DNA Anal..
02/24 HITACHI METALS : Patent Issued for Communication Module and Communication Module..
02/22 HITACHI : Data Systems All-Flash Virtual Storage Platform Named in Storage Magaz..
02/22 HITACHI : Foreign-Trade Zone (FTZ) 29--Louisville, Kentucky; Notification of Pro..
More news
Sector news : Industrial Conglomerates
03:16p GENERAL ELECTRIC : GE's Immelt says U.S. 'diverging' from the world
01:15pDJGE CHIEF : Globalization Isn't Over, It Is the End of the 'Global Elite'
06:26aDJSIME DARBY BERHAD : Bhd 2Q Net Profit MYR644 Million vs MYR285 Million
02/25 Buffett mulls change to canny Bank of America stake if dividend rises
02/24 Safran ready to discuss A400M, but won't share Airbus penalties
More sector news : Industrial Conglomerates
News from SeekingAlpha
02/14 Wave Power - Is It Going To Work?
02/07 WALL STREET BREAKFAST : Earnings Season Kicks Into High Gear
02/07 Honda, Hitachi form EV motor joint venture
02/01 Hitachi's (HTHIY) Management on Q3 2017 Results - Earnings Call Transcript
02/01 Hitachi reports FQ3 results
Financials ( JPY)
Sales 2017 9 017 811 M
EBIT 2017 542 500 M
Net income 2017 225 795 M
Debt 2017 1 960 176 M
Yield 2017 1,96%
P/E ratio 2017 13,69
P/E ratio 2018 11,34
EV / Sales 2017 0,56x
EV / Sales 2018 0,55x
Capitalization 3 059 582 M
More Financials
Duration : Period :
Hitachi, Ltd. Technical Analysis Chart | 6501 | JP3788600009 | 4-Traders
Full-screen chart
Technical analysis trends HITACHI, LTD.
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 731  JPY
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Toshiaki Higashihara Executive President, CEO & Director
Hiroaki Nakanishi Chairman
Mitsuaki Nishiyama Chief Financial Officer
Shinichiro Omori Chief Information & Transformation Officer
Norihiro Suzuki Chief Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HITACHI, LTD.-2.33%27 273
3M CO4.95%111 734
SIEMENS AG4.24%109 190
E I DU PONT DE NEMOURS..8.73%69 002
More Results